Table: Fuso Pharmaceutical - Q1 parent results

Fuso Pharmaceutical Industries

08/08/2019 05:40

Aug 8 (Reuters)- 
             Fuso Pharmaceutical Industries Ltd 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2019        Jun 30, 2018     Mar 31, 2020 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             11.75               11.36            46.20    
                 (+3.4 pct)          (-1.3 pct)       (+0.3 pct)  
  Operating        481 mln             258 mln          650 mln   
                 (+86.5 pct)         (+77.4 pct)      (-48.5 pct) 
  Recurring        598 mln             363 mln          600 mln   
                 (+64.6 pct)         (+30.7 pct)      (-53.1 pct) 
  Net              410 mln             235 mln          400 mln   
                 (+74.1 pct)         (+22.7 pct)      (-55.3 pct) 
  EPS             46.77 yen           26.85 yen        45.57 yen  
  Ann Div                             80.00 yen        60.00 yen  
  -Q2 div                             40.00 yen        30.00 yen  
  -Q4 div                             40.00 yen        30.00 yen  
  
  NOTE - Fuso Pharmaceutical Industries Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4538.T